Your browser doesn't support javascript.
loading
Axitinib after Sunitinib in Metastatic Renal Cancer: Preliminary Results from Italian "Real-World" SAX Study.
D'Aniello, Carmine; Vitale, Maria G; Farnesi, Azzurra; Calvetti, Lorenzo; Laterza, Maria M; Cavaliere, Carla; Della Pepa, Chiara; Conteduca, Vincenza; Crispo, Anna; De Vita, Ferdinando; Grillone, Francesco; Ricevuto, Enrico; De Tursi, Michele; De Vivo, Rocco; Di Napoli, Marilena; Cecere, Sabrina C; Iovane, Gelsomina; Amore, Alfonso; Piscitelli, Raffaele; Quarto, Giuseppe; Pisconti, Salvatore; Ciliberto, Gennaro; Maiolino, Piera; Muto, Paolo; Perdonà, Sisto; Berretta, Massimiliano; Naglieri, Emanuele; Galli, Luca; Cartenì, Giacomo; De Giorgi, Ugo; Pignata, Sandro; Facchini, Gaetano; Rossetti, Sabrina.
Afiliação
  • D'Aniello C; Oncology Unit, A.O.R.N. dei COLLI "Ospedali Monaldi-Cotugno-CTO," Naples, Italy.
  • Vitale MG; UOSC Oncologia Cardarelli Hospital Naples, Italy.
  • Farnesi A; Oncology Unit 2, University Hospital of Pisa Pisa, Italy.
  • Calvetti L; Ospedale San Bortolo Vicenza, Italy.
  • Laterza MM; Division of Medical Oncology, Department of Internal and Experimental Medicine "F. Magrassi," Second University of Naples - School of Medicine Naples, Italy.
  • Cavaliere C; Department of Onco-Hematology Medical Oncology, S.G. Moscati Hospital of Taranto Taranto, Italy.
  • Della Pepa C; Department of Uro-Gynaecological Oncology, Division of Medical Oncology, Istituto Nazional Tumori IRCCS "Fondazione G. Pascale," Naples, Italy.
  • Conteduca V; Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori IRCCS Meldola, Italy.
  • Crispo A; Unit of Epidemiology, Struttura Complessa di Statistica Medica, Biometria e Bioinformatica, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale," Naples, Italy.
  • De Vita F; Division of Medical Oncology, Department of Internal and Experimental Medicine "F. Magrassi," Second University of Naples - School of Medicine Naples, Italy.
  • Grillone F; Medical Oncology Unit, Azienda Ospedaliera "Mater Domini," Catanzaro, Italy.
  • Ricevuto E; Oncology Network ASL1 Abruzzo, Oncology Territorial Care Unit, Division of Medical Oncology, Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila L'Aquila, Italy.
  • De Tursi M; Department of Medical, Oral and Biotechnological Sciences, University "G. D'Annunzio," Chieti, Italy.
  • De Vivo R; Ospedale San Bortolo Vicenza, Italy.
  • Di Napoli M; Department of Uro-Gynaecological Oncology, Division of Medical Oncology, Istituto Nazional Tumori IRCCS "Fondazione G. Pascale," Naples, Italy.
  • Cecere SC; Department of Uro-Gynaecological Oncology, Division of Medical Oncology, Istituto Nazional Tumori IRCCS "Fondazione G. Pascale," Naples, Italy.
  • Iovane G; Department of Uro-Gynaecological Oncology, Division of Medical Oncology, Istituto Nazional Tumori IRCCS "Fondazione G. Pascale," Naples, Italy.
  • Amore A; Hepatobiliary Unit, Division of Abdominal Surgical Oncology, National Cancer Institute "G. Pascale Foundation," IRCCS Naples, Italy.
  • Piscitelli R; Pharmacy Unit, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale," Naples, Italy.
  • Quarto G; Division of Urology, Department of Uro-Gynaecological Oncology, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale," Naples, Italy.
  • Pisconti S; Department of Onco-Hematology Medical Oncology, S.G. Moscati Hospital of Taranto Taranto, Italy.
  • Ciliberto G; Scientific Direction, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale," Naples, Italy.
  • Maiolino P; Pharmacy Unit, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale," Naples, Italy.
  • Muto P; Division of Radiation Oncology, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale," Naples, Italy.
  • Perdonà S; Division of Urology, Department of Uro-Gynaecological Oncology, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale," Naples, Italy.
  • Berretta M; Division of Medical Oncology, CRO Aviano, Italy.
  • Naglieri E; Division of Medical Oncology, Istituto Oncologico Giovanni Paolo II Bari, Italy.
  • Galli L; Oncology Unit 2, University Hospital of Pisa Pisa, Italy.
  • Cartenì G; UOSC Oncologia Cardarelli Hospital Naples, Italy.
  • De Giorgi U; Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori IRCCS Meldola, Italy.
  • Pignata S; Department of Uro-Gynaecological Oncology, Division of Medical Oncology, Istituto Nazional Tumori IRCCS "Fondazione G. Pascale," Naples, Italy.
  • Facchini G; Department of Uro-Gynaecological Oncology, Division of Medical Oncology, Istituto Nazional Tumori IRCCS "Fondazione G. Pascale," Naples, Italy.
  • Rossetti S; Department of Uro-Gynaecological Oncology, Division of Medical Oncology, Istituto Nazional Tumori IRCCS "Fondazione G. Pascale," Naples, Italy.
Front Pharmacol ; 7: 331, 2016.
Article em En | MEDLINE | ID: mdl-27733829
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2016 Tipo de documento: Article